The post Swiss Q3 GDP contracts 0.5% amid tariff pressures – Commerzbank appeared on BitcoinEthereumNews.com. The final Swiss growth figures for the third quarter, published on Friday, were ultimately as poor as the initial estimate of growth adjusted for sport events, standing at -0.5% quarter-on-quarter. This was slightly below expectations, with the Bloomberg consensus predicting a contraction of 0.4%. This was the first negative growth since the first half of 2023, Commerzbank’s FX analyst Michael Pfister notes. First negative growth since early 2023 for Switzerland “The third quarter was significantly impacted by US tariffs, which increased to 39% at the start of August, while most major trading partners were granted lower tariffs. Net exports have essentially caused growth to slump; in the first quarter, they had the opposite effect due to front-loading effects. It is therefore advisable to consider the past three quarters in aggregate rather than focusing on individual quarters. Now that a preliminary deal has been reached with the US and tariffs are being reduced, we are likely to see better figures in the coming months.” “A more problematic issue for the Swiss economy is its dependence on the pharmaceutical industry. Until around 2014, gross value added in the pharmaceutical sector grew in line with other industries. However, since then, this relationship has become significantly decoupled. In other words, much of Switzerland’s relatively strong growth in recent years has been due to the pharmaceutical industry, with other sectors contributing less.” “This dependence could become problematic in the long term, particularly as the US administration is seeking to shift production for the US market from other countries to the US, and several large Swiss pharmaceutical companies have announced substantial investments in the US that would not be made in Switzerland. However, it will probably take several years to see the effects of such production shifts. In the short term, the contraction in the third… The post Swiss Q3 GDP contracts 0.5% amid tariff pressures – Commerzbank appeared on BitcoinEthereumNews.com. The final Swiss growth figures for the third quarter, published on Friday, were ultimately as poor as the initial estimate of growth adjusted for sport events, standing at -0.5% quarter-on-quarter. This was slightly below expectations, with the Bloomberg consensus predicting a contraction of 0.4%. This was the first negative growth since the first half of 2023, Commerzbank’s FX analyst Michael Pfister notes. First negative growth since early 2023 for Switzerland “The third quarter was significantly impacted by US tariffs, which increased to 39% at the start of August, while most major trading partners were granted lower tariffs. Net exports have essentially caused growth to slump; in the first quarter, they had the opposite effect due to front-loading effects. It is therefore advisable to consider the past three quarters in aggregate rather than focusing on individual quarters. Now that a preliminary deal has been reached with the US and tariffs are being reduced, we are likely to see better figures in the coming months.” “A more problematic issue for the Swiss economy is its dependence on the pharmaceutical industry. Until around 2014, gross value added in the pharmaceutical sector grew in line with other industries. However, since then, this relationship has become significantly decoupled. In other words, much of Switzerland’s relatively strong growth in recent years has been due to the pharmaceutical industry, with other sectors contributing less.” “This dependence could become problematic in the long term, particularly as the US administration is seeking to shift production for the US market from other countries to the US, and several large Swiss pharmaceutical companies have announced substantial investments in the US that would not be made in Switzerland. However, it will probably take several years to see the effects of such production shifts. In the short term, the contraction in the third…

Swiss Q3 GDP contracts 0.5% amid tariff pressures – Commerzbank

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The final Swiss growth figures for the third quarter, published on Friday, were ultimately as poor as the initial estimate of growth adjusted for sport events, standing at -0.5% quarter-on-quarter. This was slightly below expectations, with the Bloomberg consensus predicting a contraction of 0.4%. This was the first negative growth since the first half of 2023, Commerzbank’s FX analyst Michael Pfister notes.

First negative growth since early 2023 for Switzerland

“The third quarter was significantly impacted by US tariffs, which increased to 39% at the start of August, while most major trading partners were granted lower tariffs. Net exports have essentially caused growth to slump; in the first quarter, they had the opposite effect due to front-loading effects. It is therefore advisable to consider the past three quarters in aggregate rather than focusing on individual quarters. Now that a preliminary deal has been reached with the US and tariffs are being reduced, we are likely to see better figures in the coming months.”

“A more problematic issue for the Swiss economy is its dependence on the pharmaceutical industry. Until around 2014, gross value added in the pharmaceutical sector grew in line with other industries. However, since then, this relationship has become significantly decoupled. In other words, much of Switzerland’s relatively strong growth in recent years has been due to the pharmaceutical industry, with other sectors contributing less.”

“This dependence could become problematic in the long term, particularly as the US administration is seeking to shift production for the US market from other countries to the US, and several large Swiss pharmaceutical companies have announced substantial investments in the US that would not be made in Switzerland. However, it will probably take several years to see the effects of such production shifts. In the short term, the contraction in the third quarter due to US tariffs, and the expected recovery in growth, are likely to play a greater role. It is therefore not surprising that the Swiss Franc (CHF) gained slightly against the euro on Friday.”

Source: https://www.fxstreet.com/news/swiss-q3-gdp-contracts-05-amid-tariff-pressures-commerzbank-202512011104

Market Opportunity
4 Logo
4 Price(4)
$0.010531
$0.010531$0.010531
+0.18%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Resilient Pair Softens Below 111.00 Amidst Prevailing Bullish Momentum

Resilient Pair Softens Below 111.00 Amidst Prevailing Bullish Momentum

The post Resilient Pair Softens Below 111.00 Amidst Prevailing Bullish Momentum appeared on BitcoinEthereumNews.com. AUD/JPY Price Forecast: Resilient Pair Softens
Share
BitcoinEthereumNews2026/03/25 14:01